絞り込み

16506

広告

Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.

著者 Chettouh H , Mowforth O , Galeano-Dalmau N , Bezawada N , Ross-Innes C , MacRae S , Debiram-Beecham I , O'Donovan M , Fitzgerald RC
Gut.2017 Oct 30 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (22view , 0users)

Full Text Sources

Barrett's oesophagus is a premalignant condition that occurs in the context of gastro-oesophageal reflux. However, most Barrett's cases are undiagnosed because of reliance on endoscopy. We have developed a non-endoscopic tool: the Cytosponge, which when combined with trefoil factor 3 immunohistochemistry, can diagnose Barrett's oesophagus. We investigated whether a quantitative methylation test that is not reliant on histopathological analysis could be used to diagnose Barrett's oesophagus.
PMID: 29084829 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード